Riskpilot← Back to searchSign inGet full accessOSMEDIC ApS
APSActiveCVR 20080337Vallerødgade 4Wholesale of pharmaceutical and medical goods · NACE 4646Est. 19971 employees
Revenue 2025
DKK 2,2M
-3% vs 2024
EBITDA margin
96.9%
-2% vs 2024
Equity ratio
90.6%
Financial strength
Net profit 2025
DKK 6,8M
+74% vs 2024
| Revenue | DKK 2,2M | -3% |
| EBITDA | DKK 2,2M | -2% |
| Net profit | DKK 6,8M | +74% |
| Total assets | DKK 7,7M | +64% |
| Equity | DKK 6,9M | +72% |
| Employees | 1 | — |
Legal name
OSMEDIC ApS
CVR number
20080337
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. maj 1997
Share capital
DKK 125.000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-09-30
Financial year
January – December
Signatory rights
Selskabet tegnes af den samlede direktion
Company purpose
Selskabets formål er handel samt hermed beslægtet virksomhed
Address
Vallerødgade 4
Phone
+4545860028
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -15 | — | — | — | — | — | — | — | — | — | 1.757 | 3.830 | 2.284 | 2.225 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -45 | -31 | -78 | -69 |
| EBITDA | -15 | 2.223 | 3.029 | 2.817 | 2.318 | 2.642 | 3.332 | 2.956 | 2.362 | 3.559 | 1.711 | 3.799 | 2.206 | 2.156 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -15 | 2.223 | 3.029 | 2.817 | 2.318 | 2.642 | 3.332 | 2.956 | 2.362 | 3.559 | 1.711 | 3.799 | 2.206 | 2.156 |
| Net financials | 3.864 | 2.236 | 3.123 | 2.728 | 2.361 | 2.585 | 3.354 | 2.968 | 2.393 | 3.587 | 3.485 | 2.624 | 2.215 | 5.126 |
| Profit before tax | 3.849 | 2.221 | 3.108 | 2.684 | 2.345 | 2.570 | 3.340 | 2.956 | 2.381 | 3.575 | 5.196 | 6.423 | 4.422 | 7.282 |
| Tax | 15 | -20 | 16 | -41 | 3 | -19 | -1 | -4 | 1 | 1 | 376 | 843 | 508 | 471 |
| Net profit | 3.834 | 2.241 | 3.092 | 2.726 | 2.342 | 2.589 | 3.341 | 2.959 | 2.379 | 3.574 | 4.820 | 5.580 | 3.913 | 6.811 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3.974 | 4.767 | 3.901 | 3.219 | 3.244 | 4.200 | 3.530 | 3.116 | 2.626 | 3.726 | 6.283 | 6.730 | 4.664 | 7.654 |
| Equity | 3.959 | 2.366 | 3.217 | 2.851 | 2.467 | 2.714 | 3.466 | 2.749 | 2.504 | 3.699 | 4.945 | 5.705 | 4.038 | 6.936 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 843 | 446 | 471 |
| Short-term debt | 15 | 2.401 | 683 | 368 | 776 | 1.486 | 64 | 367 | 122 | 27 | 1.339 | 182 | 179 | 247 |
| Total debt | 15 | 2.401 | 683 | 368 | 776 | 1.486 | 64 | 367 | 122 | 27 | 1.339 | 1.025 | 626 | 717 |
EBITDA margin
96.9%
This company
15.8%
Market median
+513% vs market
20122025
Equity ratio
90.6%
This company
38.2%
Market median
+137% vs market
20122025
Return on equity
98.2%
This company
18.4%
Market median
+434% vs market
20122025
Net profit margin
306.1%
This company
8.1%
Market median
+3679% vs market
20122025
Asset turnover
0.29×
This company
1.12×
Market median
-74% vs market
20122025
Debt / equity
0.10×
This company
0.62×
Market median
+84% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2024-10-01 – 2025-09-30
- Annual report 2024Filed via CVR / Virk · Period 2023-10-01 – 2024-09-30
- Annual report 2023Filed via CVR / Virk · Period 2022-10-01 – 2023-09-30
- Annual report 2022Filed via CVR / Virk · Period 2021-10-01 – 2022-09-30
- Annual report 2021Filed via CVR / Virk · Period 2020-10-01 – 2021-09-30
- Annual report 2020Filed via CVR / Virk · Period 2019-10-01 – 2020-09-30
- Annual report 2019Filed via CVR / Virk · Period 2018-10-01 – 2019-09-30
- Annual report 2018Filed via CVR / Virk · Period 2017-10-01 – 2018-09-30
- Annual report 2017Filed via CVR / Virk · Period 2016-10-01 – 2017-09-30
- Annual report 2016Filed via CVR / Virk · Period 2015-10-01 – 2016-09-30
- Annual report 2015Filed via CVR / Virk · Period 2014-10-01 – 2015-09-30
- Annual report 2014Filed via CVR / Virk · Period 2013-10-01 – 2014-09-30
- Annual report 2013Filed via CVR / Virk · Period 2012-10-01 – 2013-09-30
- Annual report 2012Filed via CVR / Virk · Period 2011-10-01 – 2012-09-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
PB Management | Management | 1997 | — | — |
OE Management | Management | 1997 | — | — |
JR Audit | Audit | 1997 | — | — |
HA Audit | Audit | 1997 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
OSMEDIC HOLDING ApS | Company | 100.0% | 100.0% | 2000 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
OSMEDIC HOLDING ApS
OSMEDIC ApS Board members of OSMEDIC ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Preben Bang Henriksen | Management | 0 companies |
| Ole Emanuel Svendsen | Management | 0 companies |
| Jens Rye | Audit | 0 companies |
| Harry Aamann | Audit | 0 companies |